Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Advancements in Retroperitoneal Approach for Necrotizing Pancreatitis
Published on: March 15, 2024
Patients with Risk Factors for Complications Do Not Require Longer Antimicrobial Therapy for Complicated
Rishi Rattan1, Casey J Allen, Robert G Sawyer
1University of Miami Miller School of Medicine, Miami, Florida, USA.
Abstract:
A prospective, multicenter, randomized controlled trial found that four days of antibiotics for source-controlled complicated intra-abdominal infection resulted in similar outcomes when compared with a longer duration. We hypothesized that patients with specific risk factors for complications also had similar outcomes. Short-course patients with obesity, diabetes, or Acute Physiology and Chronic Health Evaluation II ≥15 from the STOP-IT trial were compared with longer duration patients. Outcomes included incidence of and days to infectious complications, mortality, and length of stay. Obese and diabetic patients had similar incidences of and days to surgical site infection, recurrent intra-abdominal infection, extra-abdominal infection, and Clostridium difficile infection. Short- and long-course patients had similar incidences of complications among patients with Acute Physiology and Chronic Health Evaluation II ≥15. However, there were fewer days to the diagnosis of surgical site infection (9.5 ± 3.4 vs 21.6 ± 6.2, P = 0.010) and extra-abdominal infection (12.4 ± 6.9 vs 21.8 ± 6.1, P = 0.029) in the short-course group. Mortality and length of stay was similar for all groups. A short course of antibiotics in complicated intra-abdominal infection with source control seems to have similar outcomes to a longer course in patients with diabetes, obesity, or increased severity of illness.
Insights
A short antibiotic course for complicated intra-abdominal infections is as effective as a longer duration, even for high-risk patients with obesity or diabetes. This finding supports shorter treatment durations in specific patient groups.
Area of Science:
- Infectious Diseases
- Surgical Infections
- Clinical Trials
Background:
- Complicated intra-abdominal infections (cIAI) often require prolonged antibiotic therapy.
- Previous studies suggest shorter antibiotic durations may be effective for cIAI with source control.
- Specific patient risk factors may influence outcomes with shorter antibiotic courses.
Purpose of the Study:
- To evaluate the efficacy of a short-course (4-day) antibiotic regimen compared to a longer duration in patients with cIAI and specific risk factors.
- To assess infectious complications, mortality, and length of stay in subgroups including patients with obesity, diabetes, or high illness severity (APACHE II score ≥15).
Main Methods:
- Analysis of data from a prospective, multicenter, randomized controlled trial (STOP-IT).
- Comparison of short-course versus long-course antibiotic treatment in patients with cIAI and risk factors like obesity, diabetes, or APACHE II score ≥15.
- Outcomes measured included incidence and time to infectious complications, mortality, and hospital length of stay.
Main Results:
- Short-course antibiotics yielded similar outcomes to longer courses for obese and diabetic patients regarding surgical site infections, recurrent intra-abdominal infections, extra-abdominal infections, and Clostridium difficile infections.
- Patients with APACHE II score ≥15 also showed similar complication rates between short- and long-course groups.
- However, the short-course group experienced faster diagnosis of surgical site infections and extra-abdominal infections.
- Mortality and length of stay were comparable across all treatment arms and risk factor groups.
Conclusions:
- A 4-day antibiotic course for source-controlled cIAI is as effective as longer durations in patients with obesity, diabetes, or elevated illness severity.
- Shorter antibiotic durations appear safe and effective, potentially reducing antibiotic exposure in high-risk populations.
- These findings support the judicious use of shorter antibiotic courses in selected cIAI patients.
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Urinary Tract Infection IV: Nursing Management
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
